BridgeMD
New treatment option for Generalized Anxiety Disorder (GAD)
Official title Personalized AI-Driven Models in Cognitive Behavioral Therapy for Anxiety
ClinicalTrials.gov ID: NCT07430800
What this study is testing
- What it's testing
- Untreated anxiety undermines long-term physical and emotional wellbeing, especially among college students, with rates worsening since the onset of the COVID-19 pandemic. Cognitive Behavioral Therapy (CBT) is the leading evidence-based intervention for anxiety, but many students fail to complete exercises between CBT sessions, reducing its effectiveness.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Are 18 years of age or older
- Are university students
- Are able to communicate in English
- Have corrected-to-normal vision and hearing
- Consent to have audio/video/interaction data recorded as part of the study
You likely can't join if
- Are less than 18 years of age
- Are not university students
- Are not able to communicate in English
- Do not have corrected-to-normal vision and hearing
- Do not consent to have audio/video/interaction data recorded as part of the study
- Have a GAD-7 (Generalized Anxiety Disorder-7 item) score of 4 or lower.
See the full eligibility criteria
- Are 18 years of age or older
- Are university students
- Are able to communicate in English
- Have corrected-to-normal vision and hearing
- Consent to have audio/video/interaction data recorded as part of the study
- Have a GAD-7 (Generalized Anxiety Disorder-7 item) score of 5 or greater, indicating mild to elevated levels of self-reported symptoms of anxiety
- Have a lower than minimal level of suicidality risk as measured by the Columbia Suicide Severity Rating Scale (C-SSRS) during screening ("NO" responses to items 3, 4, 5, and 6 on C-SSRS)
- Having access to home WiFi
- Are less than 18 years of age
- Are not university students
- Are not able to communicate in English
- Do not have corrected-to-normal vision and hearing
- Do not consent to have audio/video/interaction data recorded as part of the study
- Have a GAD-7 (Generalized Anxiety Disorder-7 item) score of 4 or lower.
- Higher than a minimal level of suicidality risk as measured by the Columbia Suicide Severity Rating Scale (C-SSRS) during screening ("YES" responses to items 3, 4, 5, or 6 on C-SSRS)
- Don't have access to home WiFi
The study team makes the final eligibility decision.
Where it's taking place
- Los Angeles, California, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Los Angeles, California, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.